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Ljubljana, Slovenia. 29th September – 2nd October 2016Genomics and Biology of Exercise is a field of research
aiming at understanding how genetic variations influ-
ence adaptations to exercise training in healthy and
diseased populations, elite athletes, and predisposition
to exercise-related injuries. While the pioneering
HERITAGE family study (HEalth, RIsk factors, exercise
Training And GEnetics) acknowledged the importance of
large, collaborative enterprises to obtain reliable results
[1], many of the studies in the field have suffered from
methodological errors, resulting in invalidated and non-
replicated results [2]. Consequently, after more than
20 years of research in the field there remains no set
of genetic variants available to predict exercise per-
formance and predisposition to injuries in individuals
[3]. However, the field of Genomics and Biology of
Exercise is undergoing an urgently needed paradigm
shift as an ever increasing number of scientists realise
that working together is the best way to advance the
field.
Why is working within consortia the best way to
advance the field?
Consortia are initiatives that bring together efforts of
several research groups, institutions and often several
involved scientists from several countries to answer key
questions in a field of research. There are many reasons
why consortia are not only the preferred framework, but
are actually necessary if we seek robust, reproducible,
and translational results in exercise genomics.
It is now well-established that adaptations to exercise
training, athletic performance, and predisposition to
sports injuries are complex, polygenic traits that are
highly heritable [2]. Heritability measures have been* Correspondence: Nir.Eynon@vu.edu.au
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they correspond to the proportion of variance in
performance and performance-related traits that is
explained by heritable factors. Linkage analyses and gen-
etic association studies allowed the identification of
chromosomal regions and common single nucleotide
polymorphisms associated with performance-related
phenotypes [6]. However, the proportion of variance
explained by all these variants has turned out to be much
lower than the heritability measures derived from twin
and family studies. This common phenomenon in com-
plex traits is termed “missing heritability” [7] and it has
been hypothesised that it occurs because traits are influ-
enced by the combined influence of thousands of com-
mon genetic variants with very small effect sizes, as well
as possibly rare variants with larger effect sizes [8, 9]. This
directly implies that large sample sizes are necessary to
obtain enough statistical power to detect those variants,
and that diverse cohorts should be studied if we wish the
whole population spectrum to benefit from research
findings in exercise genomics. This is particularly the
case for observational studies that require even larger
sample sizes because of their uncontrolled setting
[10]. Finally, validation and replication of findings is
of paramount importance. For instance, the attempt to
replicate genetic variants discovered in the HERITAGE
Caucasian cohort showed very limited success [11].
This is where consortia can be helpful by raising the
number of participants and providing a wide range of
populations to study.
The current direction taken by exercise genomics
strongly calls for the development of collaboration be-
tween research centres. It is becoming increasingly clear
that we require to distance ourselves from small
candidate-gene driven studies to obtain a more global,
unbiased picture of how the genome influences the
response to exercise by conducting whole genome
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athletes was published recently and was a fruit of the
GAMES consortium [12]. The study involved a total of
1520 endurance athletes (835 who took part in endurance
events in World Championships and/or Olympic Games)
and 2760 matched sedentary controls. Given the low
sample size, GAMES was underpowered to identify
alleles with small effect sizes. However, some of the
suggestive associations identified should be explored in
expanded comparisons of world-class endurance athletes
and non-athletic cohorts controls and in tightly controlled
exercise training studies.
An observed association between genetic variants and
phenotypes does not necessarily mean causation. There-
fore, following the discovery and replication phase,
mechanistic and functional studies are required to
uncover how these variants act at the molecular level.
Genetics is unlikely to yield robust results with clinical
relevance unless it is combined with transcriptomics,
proteomics and/or epigenetics to establish causal
relationships between variants and phenotypes [13]. The
latest technological advances such as next-generation
sequencing and (epi)genome editing will also hopefully
become routine procedures in the field of exercise
genomics. A corollary is that advanced bioinformatics
and biostatistical analyses to process and integrate such
a heterogeneous, vast amount of data will be dearly
needed. Here again, working in a consortium can help by
bringing together different research groups that all
specialise in different techniques that are complementary,
and by splitting the amount of work to alleviate the
burden put on each group. It should also be noted
that from the fundamental biological ground work
done at the genetic and molecular levels, we must
then move to the applied field to improve clinical
practice, standardised protocols to prevent injury,
maximise training output and perhaps translate find-
ings to different populations for treating muscle and
cardiovascular-related diseases. Regular cross-talk
between fundamental and applied research groups
working in a consortium are needed to ensure that
the exerted efforts at the fundamental level can be
used and translated to a more applied and clinical
setting later on.
The establishment of the Athlome consortium and
other consortia to speed up discoveries
Initiating large collaborations, especially between nu-
merous research groups and institutions, are not an
easy task. Each laboratory has its own standard oper-
ating procedures for essays and data storage/sharing,
protocols and equipment. To obtain comparable re-
sults, collaborators require establishing common exer-
cise protocols, standardising their testing procedures,updating some of their equipment, and establishing
ground rules for data sharing without compromising
their own independency. It is also important for all
consortia members to explicitly voice their own goals
and identities, to remap stakeholders and interests
periodically and to adapt social and technical systems
to emerging needs and practices [14]. Ultimately, all
those initial efforts will be greatly rewarded by the
significance and the relevance of the findings. It is
virtually impossible for a single research group to
conduct all the necessary studies that will answer
questions in exercise genomics with sufficient depth.
Consortia and large-scale studies are made to split the
research effort and to speed up discoveries, thanks to each
group’s expertise in different domains. For instance, the
recently established Athlome consortium project
(www.athlomeconsortium.org) is currently an umbrella
for more than 15 research groups to share and combine
genomic, epigenomic, transcriptomic, proteomic, and
metabolomic data to address key questions in three main
research areas: elite performance, training response, and
predisposition to injuries [15]. Within the Athlome con-
sortium, the Gene SMART (Skeletal Muscle Response
to Training) study is an example of tightly controlled
exercise training study collecting of a variety of muscle
and blood phenotypes. This study is exploring ‘omics’ data
to understand why some people are high responders while
others are low responders to similar exercise training (The
Methods paper is available in this issue). Another
example is the National Institutes of Health Common
Fund program titled Molecular Transducers of Phys-
ical Activity Consortium (MoTrPAC) that is gathering
23 institutions in a common effort to catalogue the
biological molecules affected by exercise in people, to
assemble a comprehensive map of the molecular
changes that occur in response to movement and,
when possible, relate these changes to the benefits of
physical activity [3, 16]. These recently launched con-
sortia demonstrate a strong drive to move the field of
exercise genomics in to the next level, with great
hope to see these consortia succeed where individual
research groups have failed.
The manuscripts published in this issue summarise
some of the recent research multi-centre advances in
the field of exercise genomics. The overall goal, as
stated elsewhere [15, 17, 18] is to identify the
sequence variation that plays a causal role in response
to exercise and athlete’s predisposition to injuries and
illness, and then to use this information to generate
insights into the biology of health and disease that
can support clinical translation.Funding
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